Results 271 to 280 of about 208,281 (313)
c-Abl Inhibitors in Parkinson's: Exploring Hypotheses on Alpha-Synuclein Modulation. [PDF]
Nargish J, Baishya HJ, Sola P.
europepmc +1 more source
Beyond estimates: optimizing surgical strategies through accurate blood loss measurement. [PDF]
Furlanetto A+8 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Ablative and Fractional Ablative Lasers
Dermatologic Clinics, 2009The field of nonsurgical laser resurfacing for aesthetic enhancement continues to improve with new research and technological advances. Since its beginnings in the 1980s, the laser-resurfacing industry has produced a multitude of devices employing ablative, nonablative, and fractional ablative technologies.
Robert Anolik+8 more
openaire +2 more sources
Inhibitors of ABL and the ABL-T315I Mutation
Current Topics in Medicinal Chemistry, 2008Chronic myelogenous leukemia (CML) is a hematological stem cell disorder caused by increased and unregulated growth of myeloid cells in the bone marrow, and the accumulation of excessive white blood cells. Abelson tyrosine kinase (ABL) is a non-receptor tyrosine kinase involved in cell growth and proliferation and is usually under tight control ...
John Hood+15 more
openaire +3 more sources
Skin Resurfacing: Ablative and Non-ablative Lasers [PDF]
The request for skin rejuvenating techniques is increasing. The concept of nonsurgical skin rejuvenation has been developed through the introduction of laser skin resurfacing. Laser resurfacing for skin rejuvenation was first introduced in the 1980s through the ablative carbon dioxide (CO2) laser.
Pier Luca Bencini, Stefania Guida
openaire +1 more source
Classroom provision for the able and the exceptionally able [PDF]
Ralph Callow has worked for many years with exceptionally able pupils. He describes the two recommended approaches for dealing with the challenges posed by such pupils: enrichment and acceleration. He also gives us a fascinating insight into the progress of ‘Simon’, a child of outstanding ability. It is a compliment to the profession that Simon's needs
openaire +1 more source
Blood, 2001
Chronic myelogenous leukemia (CML) has long been a hunting ground for specific therapies of cancer because the disease is initiated by a single, unique chromosomal translocation. The translocation fusion gene product is the target of the first rationally designed tumor inhibitor STI571 ...
openaire +2 more sources
Chronic myelogenous leukemia (CML) has long been a hunting ground for specific therapies of cancer because the disease is initiated by a single, unique chromosomal translocation. The translocation fusion gene product is the target of the first rationally designed tumor inhibitor STI571 ...
openaire +2 more sources